Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-24 4:30 pm Sale |
2024-07-23 | 13D | QuidelOrtho Corporation QDEL |
Carlyle Group Inc. CG |
10,327,772 15.400% |
-717,230 (-6.49%) |
Filing History |
| 2024-07-15 4:30 pm Sale |
2024-07-11 | 13D | QuidelOrtho Corporation QDEL |
Carlyle Group Inc. CG |
11,045,002 16.500% |
-721,020 (-6.13%) |
Filing History |
| 2024-07-11 5:02 pm Purchase |
2024-07-01 | 13G | Complete Solaria, Inc. CSLR |
Carlyle Group Inc. CG |
10,888,864 17.700% |
8,142,985 (+296.55%) |
Filing History |
| 2024-07-08 6:15 pm Purchase |
2024-06-28 | 13D | Cano Health, Inc. CANO |
Carlyle Group Inc. CG |
2,801,906 6.700% |
2,801,906 (New Position) |
Filing History |
| 2024-06-25 5:00 pm Purchase |
2024-06-24 | 13D | QuidelOrtho Corporation QDEL |
Carlyle Group Inc. CG |
11,766,022 17.600% |
11,766,022 (New Position) |
Filing History |
| 2024-05-14 4:30 pm Sale |
2024-05-12 | 13D | QuidelOrtho Corporation QDEL |
Carlyle Group Inc. CG |
0 0.000% |
-12,460,183 (Position Closed) |
Filing History |
| 2024-05-13 4:05 pm Sale |
2024-05-09 | 13D | eFFECTOR Therapeutics, Inc. EFTR |
Carlyle Group Inc. CG |
193,195 4.100% |
-1 (-0.00%) |
Filing History |
| 2024-03-29 4:30 pm Purchase |
2024-03-25 | 13G | Q32 Bio Inc. QTTB |
Carlyle Group Inc. CG |
1,102,741 9.200% |
1,102,741 (New Position) |
Filing History |
| 2024-03-05 4:10 pm Sale |
2024-03-01 | 13D | The Carlyle Group Inc. CG |
Carlyle Group Management L.L.C. | 140,827,506 39.000% |
-11,303,498 (-7.43%) |
Filing History |
| 2024-02-13 4:55 pm Sale |
2023-12-29 | 13G | The Carlyle Group Inc. CG |
The Vanguard Group | 24,876,188 6.890% |
-76,681 (-0.31%) |
Filing History |
| 2024-02-12 6:00 pm Purchase |
2024-02-08 | 13D | Jasper Therapeutics, Inc. JSPR |
Carlyle Group Inc. CG |
1,066,189 7.100% |
190,000 (+21.68%) |
Filing History |
| 2024-02-12 5:46 pm Sale |
2023-12-31 | 13G | ZoomInfo Technologies Inc. ZI |
Carlyle Group Inc. CG |
35,244,474 9.000% |
-1,417,995 (-3.87%) |
Filing History |
| 2024-02-12 5:45 pm Sale |
2023-12-31 | 13G | MKS Instruments, Inc. MKSI |
Carlyle Group Inc. CG |
0 0.000% |
-8,482,732 (Position Closed) |
Filing History |
| 2024-02-12 4:36 pm Purchase |
2023-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Carlyle Group Inc. CG |
3,496,808 6.100% |
561,702 (+19.14%) |
Filing History |
| 2024-02-12 4:31 pm Unchanged |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
Carlyle Group Inc. CG |
1,838,486 3.800% |
0 (Unchanged) |
Filing History |
| 2024-02-12 11:22 am Sale |
2023-12-31 | 13G | The Carlyle Group Inc. CG |
MORGAN STANLEY MS |
10,485,962 2.900% |
-12,926,684 (-55.21%) |
Filing History |
| 2024-02-09 6:14 pm Purchase |
2024-02-07 | 13G | The Carlyle Group Inc. CG |
Capital World Investors | 20,008,088 5.500% |
17,791,088 (+802.48%) |
Filing History |
| 2024-02-07 4:31 pm Purchase |
2024-01-25 | 13D | Adicet Bio, Inc. ACET |
Carlyle Group Inc. CG |
3,060,292 4.100% |
907,333 (+42.14%) |
Filing History |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | The Carlyle Group Inc. CG |
BLACKROCK INC BLK |
31,155,048 8.600% |
31,155,048 (New Position) |
Filing History |
| 2024-01-03 4:15 pm Purchase |
2023-12-31 | 13D | CommScope Holding Company, Inc. COMM |
Carlyle Group Inc. CG |
42,257,593 16.600% |
2,789,051 (+7.07%) |
Filing History |